During its first 5 years, the firm grew steadily through challenging economic times. In 2005, the company added an additional focus in the national market for contract Engineering resources. That soon became the largest segment of the company’s services, and helped Black Diamond again forge ahead in the face of economic recession – this time the housing market collapse of 2008-2009. On the heels of that recession, Black Diamond made another important addition, the company’s Life Science and Technology group in 2011. Today, providing Regulatory Affairs, Clinical, Quality and Validation professionals for Pharmaceutical, Biotech and Medical Device companies, it is the fastest growing segment of BDN’s business.